These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37869667)

  • 1. Regulations of phage therapy across the world.
    Yang Q; Le S; Zhu T; Wu N
    Front Microbiol; 2023; 14():1250848. PubMed ID: 37869667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage Therapy Regulation: From Night to Dawn.
    Fauconnier A
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30999559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain.
    Vázquez R; Díez-Martínez R; Domingo-Calap P; García P; Gutiérrez D; Muniesa M; Ruiz-Ruigómez M; Sanjuán R; Tomás M; Tormo-Mas MÁ; García P
    Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
    Furfaro LL; Payne MS; Chang BJ
    Front Cell Infect Microbiol; 2018; 8():376. PubMed ID: 30406049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global trends and hotspots of phage therapy for bacterial infection: A bibliometric visualized analysis from 2001 to 2021.
    Maimaiti Z; Li Z; Xu C; Chen J; Chai W
    Front Microbiol; 2022; 13():1067803. PubMed ID: 36699585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage Technology and Modern Medicine.
    Azam AH; Tan XE; Veeranarayanan S; Kiga K; Cui L
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European regulatory aspects of phage therapy: magistral phage preparations.
    Verbeken G; Pirnay JP
    Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects.
    Anyaegbunam NJ; Anekpo CC; Anyaegbunam ZKG; Doowuese Y; Chinaka CB; Odo OJ; Sharndama HC; Okeke OP; Mba IE
    Microbiol Res; 2022 Nov; 264():127155. PubMed ID: 35969943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage Therapy in Poland - a Centennial Journey to the First Ethically Approved Treatment Facility in Europe.
    Żaczek M; Weber-Dąbrowska B; Międzybrodzki R; Łusiak-Szelachowska M; Górski A
    Front Microbiol; 2020; 11():1056. PubMed ID: 32582061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1st German Phage Symposium-Conference Report.
    Huber I; Potapova K; Kuhn A; Schmidt H; Hinrichs J; Rohde C; Beyer W
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29596346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phascinating Phages.
    Straka M; Dubinová M; Liptáková A
    Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage therapy for human musculoskeletal and skin/soft tissue infections.
    Metsemakers WJ; Onsea J; Moriarty TF; Pruidze N; Nadareishvili L; Dadiani M; Kutateladze M
    Clin Microbiol Infect; 2023 Jun; 29(6):695-701. PubMed ID: 36669559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage therapy.
    Housby JN; Mann NH
    Drug Discov Today; 2009 Jun; 14(11-12):536-40. PubMed ID: 19508915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.
    Rohde C; Wittmann J; Kutter E
    Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.